Document:

ex10-10.htm

Exhibit 10.10

 

BANK OF COMMERCE HOLDINGS
STOCK GRANT AGREEMENT

 

THIS STOCK GRANT AGREEMENT (“Agreement”) is entered into by and between Bank of Commerce Holdings (“Company”) and [INSERT] (“Grantee”).

 

	
1.
	
Basic Terms of Award

 

	
Number of Shares of 
	  
	
Stock Subject to the Award:
	
[INSERT]

	 	 
	
Per-Share Value of Stock on
	  
	
Date of Award:
	
[INSERT]

	 	 
	
Fair Market Value on Date of 
	  
	
Award of Shares of Stock:
	
[INSERT]

	 	 
	
Amount Required to be Paid
	  
	
for Shares of Stock:
	
$0.00

	 	 
	
Date of Award:
	
[INSERT]

 

	
2.
	
Company hereby awards to Grantee the number of shares of Stock described above (“Award”).

 

	
3.
	
The Award is made under the Company’s 2010 Equity Incentive Plan (the “Plan”), a copy of which has been provided to Grantee. The terms and conditions of the Plan are hereby incorporated into this Agreement by this reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the former shall govern. Capitalized terms used in this Agreement that are not defined herein shall have the meaning given to such terms in the Plan. 

 

	
4.
	
Grantee shall have all of the rights of a shareholder with respect to shares of Stock subject to this Award.

 

	
5.
	
Shares of Stock subject to this Award shall not be issued, unless the issuance and delivery of such shares shall comply with all relevant provisions of law, including, without limitation, all securities laws, rules and regulations, and the requirements of any stock exchange upon which the Stock may then be listed. Issuance of shares of Stock is further subject to the approval of counsel for Company with respect to such compliance.

 

	
6.
	
Company, in its sole discretion, may take any actions reasonably believed by it to be required to comply with any local, state, or federal tax laws relating to the reporting or withholding of taxes attributable to the issuance of Stock subject to this Award, including, but not limited to, (i) withholding, or causing to be withheld, from any form of compensation or other amount due Grantee any amount required to be withheld under applicable tax laws, or (ii) requiring Grantee to make arrangements satisfactory to Company (including, without limitation, paying amounts or surrendering shares of Stock) to satisfy any tax obligations, as a condition to recognizing any rights of Grantee under the Award. 

 

 

1

 

 

	
7.
	
Miscellaneous.

 

	 	
a.
	
Each party agrees to cooperate fully with the other party and to execute such further instruments, documents and agreements, and to give such further written assurances, as may be reasonably requested by the other party to better evidence and reflect the transactions described herein and contemplated hereby, and to carry into effect the intents and purposes of this Agreement.

 

	 	
b.
	
All pronouns shall be deemed to include the masculine, feminine, neuter, singular or plural forms thereof, as the context may require. All references to “paragraph” shall be deemed to refer to paragraphs of this Agreement, unless otherwise specifically stated.

 

	 	
c.
	
All notices and other writings of any kind that a party to this Agreement may or is required to give hereunder to any other party hereto shall be in writing and may be delivered by personal service or overnight courier, facsimile, or registered or certified mail, return receipt requested, deposited in the United States mail with postage thereon fully prepaid, addressed (i) if to Company, to its home office, marked to the attention of the corporate secretary of Company; or (ii) if to Grantee, to his address set forth on the signature page hereof. Any notice or other writings so delivered shall be deemed given (i) if by mail, on the second (2nd) business day after mailing, and (ii) if by other means, on the date of actual receipt by the party to whom it is addressed. Any party hereto may from time to time by notice in writing served upon the other as provided herein, designate a different mailing address or a different person to which such notices or demands are thereafter to be addressed or delivered.

 

	 	
d.
	
Attorneys’ Fees. In any action at law or in equity to enforce any of the provisions or rights under this Agreement, the unsuccessful party to such litigation, as determined by the court in a final judgment or decree, shall pay the successful party all costs, expenses and reasonable attorneys' fees incurred by the successful party (including, without limitation, costs, expenses and fees on any appeal).

 

	 	
e.
	
Waiver. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.

 

	 	
f.
	
Choice of Law. It is the intention of the parties that the internal laws of the State of California (irrespective of any choice of law principles) shall govern the validity of this Agreement, the construction of its terms and the interpretation of the rights and duties of the parties.

 

 

2

 

 

	 	
g.
	
Successors in Interest. This Agreement and all of its terms, conditions and covenants are intended to be fully effective and binding, to the extent permitted by law, on the heirs, executors, administrators, successors and permitted assigns of the parties hereto.

 

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year first indicated above.

 

 

	
COMPANY
	
BANK OF COMMERCE HOLDINGS
	
 

	
 
	
a California corporation
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 

	
 
	
By 
	
 
	
 

	
 
	
Print name: Randall S. Eslick
	
 

	
 
	
Title: President & CEO
	
 

 

	
GRANTEE
	
By 
	
 
	
 

	
 
	
Address:  
	
[INSERT]
	
 

	
 
	
 
	
[INSERT]
	
 

	
 
	
 
	
 
	
 
	
 
	
 

	
 
	
Social Security No.
	
[INSERT]
	
 

  

 

ACKNOWLEDGEMENT

 

 

Grantee hereby acknowledges that he/SHE has received a copy of the Plan.

 

 

	
 
	
[INSERT]
	
 

 

 

3

 

 

CONSENT OF SPOUSE AND CERTIFICATION OF MARITAL STATUS 

 

CONSENT OF SPOUSE

 

This Consent of Spouse relates to an award by Bank of Commerce Holdings (the “Company”) of shares of Stock to [INSERT] under the Company’s 2010 Equity Incentive Plan and a related Stock Grant Agreement. The foregoing plan and agreement are sometimes referred to herein as the “Documents.” By his/her signature below, the undersigned acknowledges that he/she: 

 

	
 
	
1
	
is the spouse of the grantee of such shares; 

 

	 	
2.
	
has read the Documents and is familiar with the terms and conditions of the same; and

 

	 	
3.
	
agrees to be bound by all the terms and conditions of the Documents.

 

	
Dated: 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
[INSERT]
	
 

 

 

CERTIFICATION OF MARITAL STATUS

 

I hereby certify that I am not married.

 

 

	
 
	
[INSERT]
	
 

 

 

 

4Exhibit 10.1

 

AMENDMENT NO. 1 TO EXECUTIVE COMPENSATION
AGREEMENT

 

This Amendment No. 1 to Executive Compensation
Agreement (“Amendment No. 1”), dated as of December 30, 2015, is made by and between PharmaCyte Biotech,
Inc., a Nevada corporation (“Company”), and Gerald W. Crabtree (“Executive”).” The
Company and the Executive are each referred to in this Amendment No. 1 as a “Party” and collectively as the “Parties.”
Capitalized terms used but not defined in this Amendment No. 1 shall have the meanings given to them in the Executive Compensation
Agreement (as defined below).

 

RECITALS

 

WHEREAS, the Parties entered into
the Executive Compensation Agreement (“Executive Compensation Agreement”) as of March 10, 2015, effective as
of January 1, 2015, under which the Parties agreed upon the terms and conditions of the Executive’s employment;

 

WHEREAS, the Executive Compensation
Agreement currently provides that the Company shall grant to the Executive 2,400,000 options to purchase shares of the Company’s
common stock per year, vesting at the rate of 200,000 shares per month, subject to the Executive providing Services under the Executive
Compensation Agreement, as additional consideration, subject to the terms of the Second Stock Option Agreement, dated as of March
10, 2015, by and between the Company and the Executive;

 

WHEREAS, based on the board of directors’
grant of increased stock options to the Executive as additional consideration (vesting commencing January 1, 2016), the Company
and the Executive desire to amend the Executive Compensation Agreement as set forth below; and

 

WHEREAS, the increased stock options
granted to the Executive are subject to a Stock Option Agreement to be entered into by and between the Company and the Executive
on or about the date hereof.

 

AGREEMENT

 

NOW, THEREFORE,
the Parties, intending to be legally bound, hereby agree as follows:

 

1.       Section 2(C)
of the Executive Compensation Agreement is hereby amended and restated to read in its entirety as follows:

 

“Subject to and in consideration
of the Executive entering into this Agreement, on March 24, 2014, the Board approved the award of an option to purchase up to
10,000,000 shares of Common Stock at the fair market value on the date of grant, which award (“Option Award”)
is governed by the terms of the Stock Option Agreement dated as of March 10, 2015, by and between the Company and the Executive
in the form attached hereto. In addition, on the Commencement Date, the Company granted to the Executive 2,400,000 stock options
("Additional Option Award"), with a term of five years, with an exercise price equal to the fair market value
on the date of grant, and vesting at the rate of 200,000 shares per month, subject to the Executive providing Services under this
Agreement. The Additional Option Award is governed by the terms of the Second Stock Option Agreement dated as of March 10, 2015,
between the Company and the Executive, in the form attached hereto. Furthermore, on December 16, 2015, the Company granted to
the Executive 4,800,000 stock options ("New Option Award"), with a term of five years, with an exercise price
of $0.063, representing the fair market value on the date of grant and vesting at the rate of 400,000 shares per month, commencing
January 1, 2016, subject to the Executive providing Services under this Agreement. The New Option Award shall be governed by the
terms of a Stock Option Agreement substantially in the form attached to Amendment No. 1 to be entered into on or about the date
hereof by and between the Parties.”

 

    	 	1	 

     

    

 

 

2.Except as specifically provided in
and modified by this Amendment No. 1, the Executive Compensation Agreement is in all respects hereby ratified and confirmed. All
references to the “Agreement” or the “Executive Compensation Agreement” shall be deemed to refer to the
Executive Compensation Agreement as such document has been modified by this Amendment No. 1 (including, without limitation, references
to the “Agreement” in Section 12 of the Executive Compensation Agreement).

 

3.The provisions of Section 11 and Section
19 of the Executive Compensation Agreement shall apply to this Amendment No. 1 as if set forth in full in this Amendment No. 1,
mutatis mutandis, and are hereby incorporated by reference in this Amendment No. 1.

 

4.This Amendment No. 1 may be executed
in two or more counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and
the same instrument. Signatures delivered by facsimile or electronic mail, including by PDF, shall be effective as original signatures
for all purposes.

 

[Signature page follows]

 

    	 	2	 

     

    

 

 

IN WITNESS WHEREOF, the undersigned have executed
this Amendment on the day and year first written above.

 

	 	PHARMACYTE BIOTECH, INC.
	 	 
	 	 
	 	By: /s/ Kenneth L. Waggoner
	 	Name: Kenneth L. Waggoner
	 	Title: Chief Executive Officer, President and
	 	General Counsel
	 	 
	 	 
	 	THE EXECUTIVE
	 	 
	 	 
	 	By:  /s/ Gerald W. Crabtree
	 	Name: Gerald W. Crabtree

 

 

 

 

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]